243. Respiratory Infections — Viral: Saturday, 12:15 - 1:30 p.m.
Poster Session: Respiratory Infections — Viral
Mariana Haeberer, PhD
Pfizer
Madrid, Madrid, Spain
Antoni Torres, MD
Clínic Barcelona Hospital, Spain
Catalonia, Cantabria, Spain
Robin Bruyndonckx, n/a
P95
Leuven, Brabant Wallon, Belgium
Aleksandra Polkowska-Kramek, n/a
P95
Leuven, Brabant Wallon, Belgium
Charles Nuttens, n/a
Pfizer Inc
Paris, Ile-de-France, France
Francesca Lemme, PhD
P95
Leuven, Brussels Hoofdstedelijk Gewest, Belgium
Thao Mai Phuong Tran, n/a
P95
Leuven, Brabant Wallon, Belgium
Worku Biyadgie Ewnetu, n/a
P95
HASSELT, Limburg, Belgium
Caihua Liang, MD, PhD
Senior Director
Pfizer Inc
New York, New York, United States
Cristina Mendez Diez, PhD
Pfizer
Madrid, Madrid, Spain
Bradford J. Gessner, M.D., M.P.H.
Vice President Global Medical Lead for Respiratory Vaccines
Pfizer Biopharma Group
Collegeville, Pennsylvania, United States
Elizabeth Begier, MD, M.P.H.
Senior Director, Scientific Affairs Lead, RSV Antiviral/Adult Vaccine Program
Pfizer Vaccines
Dublin, Dublin, Ireland